Showing 81 - 100 results of 204 for search '(( significantly ((mean decrease) OR (greater decrease)) ) OR ( significant decrease decrease ))~', query time: 0.33s Refine Results
  1. 81
  2. 82
  3. 83

    Results of the LMM analysis for IOP change. by Sayaka Kimura-Uchida (22793666)

    Published 2025
    “…The mean GMS was 2.46 ± 1.33 preoperatively, and decreased to 1.32 ± 1.31 at 3 months, and 1.60 ± 1.41 at 12 months postoperatively. …”
  4. 84

    Results of the LMM analysis for GMS change. by Sayaka Kimura-Uchida (22793666)

    Published 2025
    “…The mean GMS was 2.46 ± 1.33 preoperatively, and decreased to 1.32 ± 1.31 at 3 months, and 1.60 ± 1.41 at 12 months postoperatively. …”
  5. 85
  6. 86

    Model selection based on best fit. by Angelina Mageni Lutambi (22097223)

    Published 2025
    “…The results showed that malaria incidence decreased with greater variance across Tanzania. Mean malaria incidence decreased from 0.347 (95% CI: 0.336, 0.357) in 2000 to 0.118 (95% CI: 0.114, 0.122) in 2020, relative to the increasing insecticide-treated bednets (ITNs) coverage (0.037; 95% CI: 0.036, 0.039 in 2000 to 0.496; 95% CI: 0.476, 0.517 in 2020). …”
  7. 87
  8. 88
  9. 89
  10. 90
  11. 91
  12. 92
  13. 93
  14. 94

    Opioid consumption data. by Wali U. Pirzada (22278071)

    Published 2025
    “…No significant difference was observed in the mean percentage of prescribed MMEs leftover between the two cohorts (Orthopaedic 47% vs. …”
  15. 95

    Prescription data. by Wali U. Pirzada (22278071)

    Published 2025
    “…No significant difference was observed in the mean percentage of prescribed MMEs leftover between the two cohorts (Orthopaedic 47% vs. …”
  16. 96

    Refill rate by surgical specialty. by Wali U. Pirzada (22278071)

    Published 2025
    “…No significant difference was observed in the mean percentage of prescribed MMEs leftover between the two cohorts (Orthopaedic 47% vs. …”
  17. 97

    Noncontinuous data on opioid use. by Wali U. Pirzada (22278071)

    Published 2025
    “…No significant difference was observed in the mean percentage of prescribed MMEs leftover between the two cohorts (Orthopaedic 47% vs. …”
  18. 98

    Data Sheet 1_Analysis of pharmacotherapeutic approaches for multiple myeloma and correlated renal and pulmonary impairments: a retrospective real-world registry study in the Greate... by Ayman Alhejazi (21092054)

    Published 2025
    “…Background<p>Multiple myeloma (MM) is a plasma cell malignancy with significant unmet medical needs, particularly in the treatment of relapsed and refractory disease. …”
  19. 99
  20. 100